Pulmonary embolism in cases of COVID-19.

We describe the clinical course of three patients admitted with SARS-CoV-2 infection and respiratory distress, where pulmonary embolism was detected during the course of the hospitalisation. Two of the cases occurred despite early institution of standard dosage of low molecular weight heparin thromboprophylaxis, and in one case, pulmonary embolism was diagnosed during the convalescent phase of an otherwise benign COVID-19 disease course.
INTERPRETATION: These cases highlight the importance of awareness of the potentially increased incidence of venous thromboembolism in COVID-19 disease. Further research is required to establish appropriate clinical management guidelines for prevention of thromboembolic complications in COVID-19.
PMID: 32463186 [PubMed - in process]

Source: Tidsskrift for den Norske Laegeforening - May 25, 2020 Category: General Medicine Authors: Tveita A, Hestenes S, Sporastøyl ER, Pettersen SA, Neple BL, Myrstad M, Tveit A, Frøen H, Svendsen J, Rønning EJ Tags: Tidsskr Nor Laegeforen Source Type: research